Hydrogen Peroxide as an Adjuvant Therapy for COVID-19: A Case Series of Patients and Caregivers in the Mexico City Metropolitan Area

Table 5

Clinical course, laboratory, and imaging studies (n = 23).

Studies performed and disease course	Number	Percent
Tested for COVID-19 (labs only)	12	52
Tested positive for COVID-19 (RT-PCR)	11	92
With chest X-ray or CT scan	14	61
Without chest X-ray or CT scan	9	39
With laboratory studies	3	13
Without laboratory studies	20	87
Hospitalized	2	9
Death	0	0
	Days
First improvement average days (min–max)	2.5 (1–8)
Mostly better average days (min–max)	6.2 (2–11)
Completely better average days (min–max)	9.5 (3–15)